At the same time, the combination treatment of SK and PYCR1 downregulation can significantly enhance SK-induced autophagy and apoptosis in HCC cells, inducing autophagy formation, LC3 redistribution, apoptotic rates, the levels of autophagy and apoptosis-related proteins. This evidence concerns the gene MAP1LC3A and hepatocellular carcinoma.